1-7 of 7
Jacobus Pfisterer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant

Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Füssel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schröder, Alexander Burges, Antje Belau, Lars Hanker, Jan Dominik Kuhlmann
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (21): 4660–4668.
https://doi.org/10.1158/1078-0432.CCR-22-1326
Published: 01 November 2022
View article titled, Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A<sub>165</sub>b, an Antiangiogenic VEGF-A Splice Variant
Open the PDF for Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A<sub>165</sub>b, an Antiangiogenic VEGF-A Splice Variant in another window
Includes: Supplementary data
Journal Articles

Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer

Florian Heitz, Stefan Kommoss, Roshan Tourani, Anthony Grandelis, Locke Uppendahl, Constantin Aliferis, Alexander Burges, Chen Wang, Ulrich Canzler, Jinhua Wang, Antje Belau, Sonia Prader, Lars Hanker, Sisi Ma, Beyhan Ataseven, Felix Hilpert, Stephanie Schneider, Jalid Sehouli, Rainer Kimmig, Christian Kurzeder, Barbara Schmalfeldt, Elena I. Braicu, Philipp Harter, Sean C. Dowdy, Boris J. Winterhoff, Jacobus Pfisterer, Andreas du Bois
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (1): 213–219.
https://doi.org/10.1158/1078-0432.CCR-19-1741
Published: 03 January 2020
View article titled, Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Open the PDF for Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study

Olivier Colomban, Michel Tod, Alexandra Leary, Isabelle Ray-Coquard, Alain Lortholary, Anne Claire Hardy-Bessard, Jacobus Pfisterer, Andreas Du Bois, Christian Kurzeder, Alexander Burges, Julien Péron, Gilles Freyer, Benoit You
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5342–5350.
https://doi.org/10.1158/1078-0432.CCR-18-3335
Published: 03 September 2019
View article titled, Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Open the PDF for Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study in another window
Includes: Supplementary data
Journal Articles

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes

Stefan Kommoss, Boris Winterhoff, Ann L. Oberg, Gottfried E. Konecny, Chen Wang, Shaun M. Riska, Jian-Bing Fan, Matthew J. Maurer, Craig April, Viji Shridhar, Friedrich Kommoss, Andreas du Bois, Felix Hilpert, Sven Mahner, Klaus Baumann, Willibald Schroeder, Alexander Burges, Ulrich Canzler, Jeremy Chien, Andrew C. Embleton, Mahesh Parmar, Richard Kaplan, Timothy Perren, Lynn C. Hartmann, Ellen L. Goode, Sean C. Dowdy, Jacobus Pfisterer
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3794–3801.
https://doi.org/10.1158/1078-0432.CCR-16-2196
Published: 13 July 2017
View article titled, Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes
Open the PDF for Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes in another window
Includes: Supplementary data
Journal Articles

Abstract B14: Rapid RNA-based histotyping of ovarian carcinomas

Michael S. Anglesio, Aline Talhouk, Steve E. Kalloger, Gholamreza Haffari, Robertson Mackenzie, Martin Cheung, Janine Senz, Christine Chow, Sherman Lau, Maria Intermaggio, Susan J. Ramus, Andreas du Bois, Jacobus Pfisterer, Jessica N. McAlpine, Friedrich Kommoss, Blake Gilks, Stefan Kommoss, David G. Huntsman
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): B14.
https://doi.org/10.1158/1078-0432.OVCA13-B14
Published: 13 May 2014
View article titled, Abstract B14: Rapid RNA-based histotyping of ovarian carcinomas
Journal Articles

Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study

Alexander Burges, Pauline Wimberger, Carolin Kümper, Vera Gorbounova, Harald Sommer, Barbara Schmalfeldt, Jacobus Pfisterer, Michail Lichinitser, Anatoliy Makhson, Vladimir Moiseyenko, Angelika Lahr, Elisabeth Schulze, Michael Jäger, Michael A. Ströhlein, Markus Maria Heiss, Thomas Gottwald, Horst Lindhofer, Rainer Kimmig
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3899–3905.
https://doi.org/10.1158/1078-0432.CCR-06-2769
Published: 02 July 2007
View article titled, Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study
Open the PDF for Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study in another window
Journal Articles

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma

Ivo Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, Lisa M. Sapinoso, Keith Ching, Henry Frierson, Jr., Karen Bräutigam, Jalid Sehouli, Elmar Stickeler, Dominique Könsgen, Felix Hilpert, Constantin S. von Kaisenberg, Jacobus Pfisterer, Thomas Bauknecht, Walter Jonat, Norbert Arnold, Garret M. Hampton
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 458–466.
https://doi.org/10.1158/1078-0432.CCR-06-0691
Published: 25 January 2007
View article titled, An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma
Open the PDF for An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma in another window
Includes: Supplementary data